Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1090
https://www.valueinhealthjournal.com/article/S1098-3015(15)03166-6/fulltext
Title : Pharmacoeconomic Analysis of the use of Everolimus Compared to Axitinib in Second Line Therapy of Patients with Metastatic Renal Cell Carcinoma
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03166-6&doi=10.1016/j.jval.2015.09.1090
First page : A442
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 590
Categories :
Tags :
Regions :
ViH Article Tags :